HANWHA GENERAL INSURANCE announced on the 7th that it has launched a customized product called 'Hanwha Health Growing Childhood Insurance Non-Dividend' for parents raising infants and young children.
Children under the age of 5 have weak immune systems and immature bodily organs, making them susceptible to various diseases. They may suffer from high fever and could suddenly have swollen airways, making it difficult to breathe (croup), or develop red spots all over their bodies accompanied by pain (allergic purpura), and they may also exhibit hypoxic symptoms due to asthma or pneumonia. If initial responses are inadequate, the situation can escalate to severe cases, often resulting in urgent visits to the emergency room.
This product has enhanced its competitiveness by discovering new areas previously not covered, including various emergencies and lifestyle diseases that arise while raising children. It includes five special clauses, such as the 'diagnostic expense for febrile seizures,' which recently received exclusive usage rights from the General Insurance Association of Korea.
First, it covers diagnostic expenses for febrile seizures, croup, and epiglottitis, which are prone to occur frequently in infants and young children. It also provides coverage for diagnostic expenses in severe lifestyle diseases when conditions such as asthma, pneumonia, hand-foot-and-mouth disease, croup, and epiglottitis occur with hypoxia.
Coverage for emergencies has also diversified. It includes a special clause covering treatment expenses for emergency visits due to high fever (emergency) and has detailed collateral for emergency room treatment expenses. A special clause for emergency room treatment expenses (emergency, by KTAS severity classification) has been added, offering greater coverage amounts for more severe cases, enhancing practicality.
Additionally, HANWHA HEALTH GROWING CHILDHOOD INSURANCE has introduced a 30-year maturity feature in a non-termination product, allowing customers to enroll at affordable premiums for a short period, thereby expanding customer choices and enhancing price competitiveness.
Furthermore, it thoroughly covers cancer, brain, and cardiovascular diseases through collaterals such as specific treatment expenses after cancer diagnosis, high-class cancer specific treatment expenses, and circulatory system disease specific treatment expenses.
A source from HANWHA GENERAL INSURANCE stated, "This product was launched to alleviate the burdens of women raising young children as a leading partner in women's wellness by encompassing various protections," adding, "We will continue to enhance product competitiveness that caters to customers across all generations, starting with women's health insurance."